Analyst Ratings for Alnylam Pharmaceuticals (ALNY)
ALNY Rating Summary
ALNY Price Target Summary
- Highest: $580.00 (Goldman Sachs)
- Lowest: $330.00 (Jefferies)
- Average: $446.36
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$446.36 (+67.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan » Updated 7/22/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
400.00 (420.00) |
286.27 (266.99) |
-6.73% | Details |
| 5/18/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
380.00 (N/A) |
286.98 (266.99) |
-6.97% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
